The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia, Clinical Laboratory licensure.
The licensure allows physicians in Rhode Island to order the IMMray PanCan-d test for their patients.
“Receiving licensure in Rhode Island now allows us to offer IMMray PanCan-d in 46 states. We expect additional state licensures to follow, as we work to make IMMray PanCan-d accessible to patients across the United States who are at risk for pancreatic cancer,” says Jeff Borcherding, Chief Executive Officer of Immunovia, Inc.
Photo of Jeff Borcherding